Your browser doesn't support javascript.
loading
Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysis.
Minkove, Samuel J; Sun, Junfeng; Li, Yan; Cui, Xizhong; Cooper, Diane; Eichacker, Peter Q; Torabi-Parizi, Parizad.
Afiliação
  • Minkove SJ; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Sun J; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Li Y; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Cui X; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Cooper D; NIH Library, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Eichacker PQ; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Torabi-Parizi P; Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Rev Med Virol ; 32(5): e2352, 2022 09.
Article em En | MEDLINE | ID: mdl-35416370
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article